PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
出版年份 2014 全文链接
标题
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
作者
关键词
-
出版物
NATURE
Volume 514, Issue 7521, Pages 247-251
出版商
Springer Nature
发表日期
2014-08-12
DOI
10.1038/nature13561
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The RasGAP Gene, RASAL2, Is a Tumor and Metastasis Suppressor
- (2013) Sara Koenig McLaughlin et al. CANCER CELL
- Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in Nras-Driven Hematopoietic Transformation
- (2013) J. Xu et al. Cancer Discovery
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice
- (2012) Tiffany Chang et al. JOURNAL OF CLINICAL INVESTIGATION
- MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
- (2012) Walter J. Jessen et al. JOURNAL OF CLINICAL INVESTIGATION
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
- (2011) Thomas De Raedt et al. CANCER CELL
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors
- (2011) Eline Beert et al. GENES CHROMOSOMES & CANCER
- Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
- (2010) Martin Sauvageau et al. Cell Stem Cell
- Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
- (2010) V.-F. Mautner et al. JOURNAL OF MEDICAL GENETICS
- Selective activation of p53-mediated tumour suppression in high-grade tumours
- (2010) Melissa R. Junttila et al. NATURE
- Stage-specific sensitivity to p53 restoration during lung cancer progression
- (2010) David M. Feldser et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
- (2010) Junxia Min et al. NATURE MEDICINE
- Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes
- (2010) Diego Pasini et al. NUCLEIC ACIDS RESEARCH
- Proteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in Gliomagenesis
- (2009) Lauren T. McGillicuddy et al. CANCER CELL
- Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
- (2009) Brigitte C. Widemann Current Oncology Reports
- TORC1 Is Essential for NF1-Associated Malignancies
- (2008) Cory M. Johannessen et al. CURRENT BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search